Table 1.
Age and HPV distribution in 200 women enrolled in the study.
| Variable | Overall N = 200 |
HIV-uninfected N = 151 |
HIV-infected N = 49 |
P-value |
|---|---|---|---|---|
| Median age (IQR) | 42.0 (33.0, 48.0) | 40.0 (31.0, 48.0) | 44.0 (36.0, 48.0) | 0.062 a |
| Any HPV, b n (%) | 0.022 c | |||
| Negative | 151 (75.5%) | 120 (79.5%) | 31 (63.3%) | |
| Positive | 49 (24.5%) | 31 (20.5%) | 18 (36.7%) | |
| HPV 16, n (%) | 0.782 c | |||
| Negative | 186 (93.0%) | 140 (92.7%) | 46 (93.9%) | |
| Positive | 14 (7.0%) | 11 (7.3%) | 3 (6.1%) | |
| HPV 18, n (%) | 0.720 d | |||
| Negative | 197 (98.5%) | 149 (98.7%) | 48 (98.0%) | |
| Positive | 3 (1.5%) | 2 (1.3%) | 1 (2.0%) | |
| HPV non-16/18,
e
n (%) |
0.001 c | |||
| Negative | 165 (82.5%) | 132 (87.4%) | 33 (67.3%) | |
| Positive | 35 (17.5%) | 19 (12.6%) | 16 (32.7%) |
HPV: human papillomavirus.
a
P-value from t-test.
b
HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.
c
P-value from chi-square test.
d
P-value from Fisher’s exact test.
e
HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.